Caliper Life Sciences, Inc. (Nasdaq: CALP) says that Shimazdu Scientific Instruments, Inc. has agreed to remove one of its DNA and RNA sequencers from the U.S. market after the company’s settled a 14-month patent dispute.
The Hopkinton, Mass.-based lab equipment and services provider had alleged that Shimazu’s MCE-202 MultiNA microchip electrophoresis system infringed on 11 different U.S. patents held by Caliper. The MultiNA is a microchip electrophoresis system the company says can quickly and easily perform DNA and RNA nucleic acid size confirmation and quantitation in life science research.
Caliper filed the suit in United States District Court for the Eastern District of Texas in January 2009, saying the product infringed on patents it held for its microfluidic LabChip(R) technology.
Terms of the settlement were not announced, but Shimazdu did not admit any wrongdoing. However, the company has discontinued sales of the MultiNA system in the United States.